Design
Review
No takes yet. Share an insight, caveat, or question.
Endothelial dysfunction may inform CV risk assessment; leaves open targeted NO therapies pending interventional trials.
Leopoldo Raij (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: